Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
BPC 157 was also shown to time-dependently activate the VEGFR2-Akt-eNOS signalling pathway
It contains methylcobalamin (vitamin B12), pyridoxine (vitamin B6), and nicotinamide, which help relieve symptoms such as numbness, tingling, weakness, fatigue, and nerve pain associated with vitamin B deficiency
Cyanocobalamin (B 12)
The Melbourne-based company, which does not manufacture the drug, claims it is a potential treatment for cartilage and muscle damage and even osteoarthritis, though there is absolutely no clinical evidence of that
Improve sleep quality
Following administration in animal models: BPC-157 demonstrates rapid systemic distribution within 15-30 minutes of administration TB-500 shows tissue-specific accumulation with preferential uptake in injured areas GHK-Cu exhibits copper-mediated transport and tissue binding characteristics Combined formulation provides both immediate and sustained bioactivity Distribution studies suggest that while each peptide follows distinct pathways, injury sites tend to concentrate all three components, potentially enhancing local therapeutic effects through multiple mechanisms
US$ 20.17
US$ 26.72
US$ 24.13
US$ 28.06
